Efficacy and safety of the currently recommended regimens with direct acting antiviral(s) (DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. A Greek multicenter real-life cohort study. George V. Papatheodoridis , Andreas Kapatais , Ioannis Goulis , Ioannis S. Elefsiniotis , Jiannis Vlachogiannakos , Spilios Manolakopoulos , George N. Dalekos , John Koskinas , Stylianos Karatapanis , Ioannis Ketikoglou , Melanie Deutsch , Emanuel K. Manesis , Vassilios A. Sevastianos , Maria J. Schina , Christos K. Triantos , Evangelos Cholongitas , Maria-Vasiliki Papageorgiou , Emmanouil Sinakos , Theofanie Karaoulani , Argyro Koukoufiki , Eftychia Evangelidou , Dimitrios Karagiannakis , Anastasia Kourikou , Eirini I. Rigopoulou , Maria Tampaki , Georgios Ntetskas , Theodoros Voulgaris , Chrysostomos Tsolias , Panagiota Ioannidou , Evangelos Akriviadis HEPATOLOGY（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
